HCA Healthcare (NYSE:HCA) Price Target Raised to $558.00

HCA Healthcare (NYSE:HCA) had its price objective raised by analysts at The Goldman Sachs Group from $520.00 to $558.00 in a research report issued on Wednesday,MarketScreener reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price suggests a potential upside of 15.82% from the stock’s previous close.

Several other equities analysts have also recently weighed in on the stock. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Wednesday. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Finally, Royal Bank Of Canada raised their price target on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $518.76.

HCA Healthcare Stock Performance

HCA traded down $0.73 during midday trading on Wednesday, reaching $481.80. 19,542 shares of the company were exchanged, compared to its average volume of 1,101,804. HCA Healthcare has a one year low of $295.00 and a one year high of $527.55. The stock has a market capitalization of $109.94 billion, a P/E ratio of 16.98, a PEG ratio of 1.38 and a beta of 1.36. The stock’s 50-day simple moving average is $481.14 and its 200 day simple moving average is $436.60.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period in the previous year, the company posted $6.22 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current year.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently bought and sold shares of HCA. Brighton Jones LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC increased its stake in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its holdings in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in HCA Healthcare by 4.5% during the second quarter. Janney Montgomery Scott LLC now owns 14,633 shares of the company’s stock valued at $5,606,000 after acquiring an additional 636 shares in the last quarter. Finally, Capital Investment Advisors LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth about $234,000. Institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 earnings beat and raised guidance — HCA reported $8.01 EPS vs. $7.37 expected and set FY2026 guidance of $29.10–$31.50, which pushed shares higher on the earnings gap-up. Article Title
• Positive Sentiment: Analyst upgrades and material price-target increases — Multiple firms raised targets (Jefferies to $590, Deutsche Bank to $558, RBC to $555, Truist to $546), signaling investor confidence in HCA’s outlook and amplifying buy-side momentum. Article Title Article Title Article Title
• Positive Sentiment: Strategic push into outpatient and acquisition opportunities — Management is accelerating outpatient growth and pursuing bolt-on acquisitions and freestanding sites to capture lower-cost volumes and expand margins. Article Title Article Title
• Positive Sentiment: Quality recognition — Several HCA hospitals were named on Healthgrades’ America’s Best Hospitals lists, supporting brand/market positioning and potentially helping referrals. Article Title
• Neutral Sentiment: Analysts say the “story is shifting” — Commentary highlights changing drivers after the target resets (mix of margin leverage from outpatient vs. near-term headwinds); useful for framing expectations but not an immediate directional catalyst. Article Title
• Neutral Sentiment: Local market activity and freestanding ER growth — HCA’s build-out (e.g., ER south of Fort Myers) and other Florida health systems breaking ground on freestanding EDs signal both expansion opportunities and intensifying local competition. Article Title Article Title
• Negative Sentiment: Federal policy shifts could create headwinds — Management is monitoring potential reimbursement and regulatory changes that could pressure margins or utilization; this is a risk to watch despite the upbeat near-term tone. Article Title

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.